This anthology provides a collection of new essays on ethical and philosophical issues that concern the development, dispensing, and use of pharmaceuticals. It brings together critical ethical issues in pharmaceutics that have not been included in any collection (e.g., the ethics of patients as researchers). In addition, it includes philosophical issues that are not within the traditional domain of applied ethics. For example, a game-theoretic approach to combating the emergence of antibiotic-resistent pathogens by spreading altruism. A tripartite distinction provides an organized series of discussions that shows the interrelatedness of philosophical issues from the creation of pharmaceuticals, the creation of demand for them, through their delivery to their ultimate consumption.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
"This book does a good job of covering general contemporary pharmaceutical issues in dealing with the explosion of innovation and progress in this field over the last ten years. ... All in all, I highly recommend this book not just for pharmacy students, but all those who practice medicine, especially those who do so in an academic or research setting. ... Those suffering from complex health problems, like addiction, diabetes or depression, would find this book particularly helpful." (Hans Krauch, Metapsychology Online Reviews, metapsychology.mentalhelp.net, Vol. 22 (5), January, 2018)
"The purpose is to assert philosophical arguments that address key issues in pharmaceutical research and development, dispensing and access, and on-label and off-label use. ... the appropriate audience is broader and includes those in both academic and public arenas: philosophers, bioethicists, health policy makers, and others working in the medical humanities." (Tyler Zahrli, Doody's Book Reviews, June, 2017)
"The purpose is to assert philosophical arguments that address key issues in pharmaceutical research and development, dispensing and access, and on-label and off-label use. ... the appropriate audience is broader and includes those in both academic and public arenas: philosophers, bioethicists, health policy makers, and others working in the medical humanities." (Tyler Zahrli, Doody's Book Reviews, June, 2017)